Inside Pediatrics Spring 2017

16 / 16

16
1600 7th Avenue South
Birmingham, Alabama 35233
Clinical Trials
Open to Hem/Onc/BMT Patients
Dr. Gregory Friedman’s innovative
Phase 1 Clinical Trial of HSV G207 uses
a modified virus to attack difficult-to-
treat brain tumors. Dr. Friedman’s trial is
the culmination of many years of hard
work that began when he was a fellow at
Children’s of Alabama. The trial is the true
definition of developmental therapeutics,
with the hope for more effective and less
toxic treatments for our children battling
brain cancers.
We are currently recruiting patients from
across the country.
Contact (205) 638-5840 or visit
for more information.